Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Imperfect Test Fuels Alternative Treatments for Lyme Disease

August 24, 2015 7:45 am | by Matthew Perrone, AP Health Writer | News | Comments

Lyme disease conjures memories of checking for ticks at camp and fretting over bug bites after hikes in the woods. Read more...

TOPICS:

Surge in Flu This Winter

August 24, 2015 7:30 am | by University of Sydney | News | Comments

Figures from NSW Health indicate the number of outbreaks that have involved "type B" influenza are far higher than last year. Read more...

TOPICS:

Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of Trumenba

August 21, 2015 12:09 pm | News | Comments

Pfizer Inc. announced today positive topline results of two Phase 3 studies of Trumenba (Meningococcal Group B Vaccine). One study included approximately 3,600 healthy individuals 10 through 18 years of age, and the other study included approximately 3,300 healthy individuals 18 through 25 years of age. Read more...

TOPICS:
Advertisement

Protein Found to Control Inflammatory Response

August 21, 2015 11:59 am | by Northwestern University | News | Comments

A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses. Read more...

New Center Will Advance Life-Saving Genome-Based Diagnostic Tools

August 21, 2015 11:50 am | by UCSF | News | Comments

Building on its pioneering research into the use of genomic technology to rapidly diagnose life-threatening diseases, UC San Francisco has launched a dedicated research center to explore how this potentially transformative approach to critical care medicine could be widely integrated into healthcare settings. Read more...

TOPICS:

Diabetes Drug Shows 1st Protection from Heart Complications

August 21, 2015 11:39 am | by Linda A. Johnson, AP Business Writer | News | Comments

For the first time, there's evidence that a diabetes medication, Jardiance, reduces risk of the complications that are the top killer of diabetics: heart attacks, strokes and other cardiovascular damage. Read more...

Drug Discovery Spotlight: FDA Approves Flibanserin (Addyi)

August 21, 2015 11:07 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we've rounded up the most popular headlines from the week. Read more...

TOPICS:

CDC Labs Killed Animals by Drowning, Hyperthermia, PETA Says

August 21, 2015 10:10 am | by Seth Augenstein, Digital Reporter | News | Comments

Laboratory animals were killed in accidents or euthanized after mistakes at CDC laboratories, including mishandling of a deadly bird-flu virus, according to People for the Ethical Treatment of Animals. Read more...

TOPICS:
Advertisement

Study May Show the Way to More Effective Vaccines

August 21, 2015 8:53 am | by University of Bonn | News | Comments

Scientists have shed light on an important immune mechanism. Read more...

TOPICS:

Tissue Bank Pays Dividends for Brain Cancer Research

August 21, 2015 8:44 am | by University of Queensland | News | Comments

Metastatic brain tumors, cancers that have spread to the brain from another tumor, are currently incurable. Read more...

TOPICS:

Drug Industry Links Run Deep in Field of Sexual Medicine

August 21, 2015 8:15 am | by Matthew Perrone, AP Health Writer | News | Comments

Sprout argued that the FDA should disregard those results and instead look to monthly results from the questionnaire. Read more...

TOPICS:

EU Approves Novartis's laBCC Therapy

August 21, 2015 8:00 am | News | Comments

Advanced basal cell carcinoma is thought to represent roughly 1-10 percent of all cases of basal cell carcinoma. Read more...

TOPICS:

EMA Validates Pfizer's Marketing Authorization Application for Ibrance

August 21, 2015 7:45 am | News | Comments

The drug is used in combination with endocrine therapy for the treatment of HR+/HER2- metastatic breast cancer. Read more...

TOPICS:

Review of Modanifil Shows Drug Does Enhance Cognition

August 21, 2015 7:30 am | by University of Oxford | News | Comments

Researchers found that the performance-enhancing capacity of the smart drug varied according to the task. Read more...

TOPICS:

Study Finds Benign Conditions Triple Chance of Developing Malignancy

August 20, 2015 12:44 pm | by UCSF | News | Comments

A national risk model that gauges a woman’s chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent increase in a subset of women whose five-year risk is estimated at 3 percent or higher. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading